Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 1, 2015, Pages E10-E15

  Costopoulos, Charis ^a,b,c   Latib, Azeem ^a,b   Naganuma, Toru ^a,b   Miyazaki, Tadashi ^a,b   Sato, Katsumasa ^a,b   Figini, Filippo ^a,b   Sticchi, Alessandro ^a   Carlino, Mauro ^a   Chieffo, Alaide ^a   Montorfano, Matteo ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bifurcation; Bioresorbable vascular scaffold; Clinical outcomes; Diffuse disease

Indexed keywords

ADULT; ARTICLE; BIORESORBABLE SCAFFOLD; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY STENTING; DEATH; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MINI CRUSH TECHNIQUE; NEOVASCULARIZATION (PATHOLOGY); OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; T STENTING; TARGET VESSEL REVASCULARIZATION; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; BIODEGRADABLE IMPLANT; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DEVICES; ENDOSCOPIC ECHOGRAPHY; ITALY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROPENSITY SCORE; PROSTHESIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CARDIOVASCULAR AGENT; CHROMIUM DERIVATIVE; EVEROLIMUS; RAPAMYCIN;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHROMIUM ALLOYS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPENSITY SCORE; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84923229471     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25569     Document Type: Article

References (8)

1. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 2011;58:578-1588.
2. Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ. Stent thrombosis. J Am Coll Cardiol 2010;56:1357-1365.
3. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, Reilly JP, Zoghbi G, Holper E, Stone GW. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensusdocument from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol 2013;62:1563-1570.
4. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
5. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-227.
6. Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A, Varbella F, Mauri F, Valgimigli M, Arampatzis C, Sabate M, Erglis A, Reimers B, Airoldi F, Laine M, Palop RL, Mikhail G, Maccarthy P, Romeo F, Colombo A. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial. Am Heart J 2013;165:65-72.
7. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-1322.
8. Latib A, Costopoulos C, Naganuma T, Colombo A. Which patients could benefit the most from bioresorbable vascular scaffold implant: From clinical practice. Minerva Cardioangiol 2013;61:255-262.